Showing results (1401-1410 of 1,603) with videos related to

Sort By:
Pageof 161
Translational Lung Cancer Research|August 9, 2024
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare <i>KRAS</i> mutations: a real-world retrospective studyHaohua Jiang, Yujing Li, Yanan Wang, et al.
American Health & Drug Benefits|January 6, 2015
Effects of medicare part d on disparity implications of medication therapy management eligibility criteriaJunling Wang, Yanru Qiao, Ya-Chen Tina Shih, et al.
Neurobiology of Disease|December 6, 2014
Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucomaJi-Hong Wu, Sheng-Hai Zhang, John M Nickerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2018
Characterization of gossypol biosynthetic pathwayXiu Tian, Ju-Xin Ruan, Jin-Quan Huang, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 28, 2026
Gradient-Modified Li-Rich Manganese-Based Oxides Cathodes with Breakthrough of Kinetic Limitation for High-Performance All-Solid-State Lithium Metal BatteriesYa Chen, Ling Huang, Awais Ghani, et al.
Exploratory Research in Clinical and Social Pharmacy|January 30, 2023
Racial and ethnic disparities in Medicare Part D medication therapy management services utilizationXiaobei Dong, Chi Chun Steve Tsang, Jamie A Browning, et al.
Translational Cancer Research|March 19, 2025
Nomogram for predicting survival in breast cancer with lung metastasis based on SEER dataCheng-Liang Chen, Ni-Ya Chen, Shuo Wu, et al.
Cancers|October 28, 2023
The Significant Impacts of Interleukin-8 Genotypes on the Risk of Colorectal Cancer in TaiwanChia-Wen Tsai, Wen-Shin Chang, Te-Cheng Yueh, et al.
In Vivo (Athens, Greece)|June 23, 2022
Contribution of Cyclin-dependent Kinase Inhibitor 1B Genotypes to Childhood Leukemia RiskJen-Sheng Pei, Wen-Shin Chang, Pei-Chen Hsu, et al.
JCO Clinical Cancer Informatics|March 21, 2019
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer TherapyJessica P Hwang, Danmeng Huang, John M Vierling, et al.
Pageof 161